BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34476426)

  • 1. Point of care whole blood microfluidics for detecting and managing thrombotic and bleeding risks.
    Diamond SL; Rossi JM
    Lab Chip; 2021 Sep; 21(19):3667-3674. PubMed ID: 34476426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimum wound size for clotting: flowing blood coagulates on a single collagen fiber presenting tissue factor and von Willebrand factor.
    Zhu S; Tomaiuolo M; Diamond SL
    Integr Biol (Camb); 2016 Aug; 8(8):813-20. PubMed ID: 27339024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin Modulates Shear-Induced NETosis in Sterile Occlusive Thrombi Formed under Haemodynamic Flow.
    Yu X; Diamond SL
    Thromb Haemost; 2019 Apr; 119(4):586-593. PubMed ID: 30722079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse.
    Welsh JD; Colace TV; Muthard RW; Stalker TJ; Brass LF; Diamond SL
    J Thromb Haemost; 2012 Nov; 10(11):2344-53. PubMed ID: 22978514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels.
    Colace TV; Fogarty PF; Panckeri KA; Li R; Diamond SL
    J Thromb Haemost; 2014 Feb; 12(2):147-58. PubMed ID: 24261634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidics and coagulation biology.
    Colace TV; Tormoen GW; McCarty OJ; Diamond SL
    Annu Rev Biomed Eng; 2013; 15():283-303. PubMed ID: 23642241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
    Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
    Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.
    Pujadas-Mestres L; Lopez-Vilchez I; Arellano-Rodrigo E; Reverter JC; Lopez-Farre A; Diaz-Ricart M; Badimon JJ; Escolar G
    PLoS One; 2017; 12(2):e0171486. PubMed ID: 28192448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.
    Diamond SL
    Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Tissue Factor Localization on Blood Clot Structure and Resistance under Venous Shear.
    Govindarajan V; Zhu S; Li R; Lu Y; Diamond SL; Reifman J; Mitrophanov AY
    Biophys J; 2018 Feb; 114(4):978-991. PubMed ID: 29490257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src family kinases inhibition by dasatinib blocks initial and subsequent platelet deposition on collagen under flow, but lacks efficacy with thrombin generation.
    Zhang Y; Diamond SL
    Thromb Res; 2020 Aug; 192():141-151. PubMed ID: 32480168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of microfluidics to assess the platelet-based control of coagulation.
    Nagy M; Heemskerk JWM; Swieringa F
    Platelets; 2017 Jul; 28(5):441-448. PubMed ID: 28358995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
    Ganter MT; Hofer CK
    Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
    Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
    Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic force triggers rapid NETosis within sterile thrombotic occlusions.
    Yu X; Tan J; Diamond SL
    J Thromb Haemost; 2018 Feb; 16(2):316-329. PubMed ID: 29156107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo recapitulation of trauma-induced coagulopathy and preliminary assessment of trauma patient platelet function under flow using microfluidic technology.
    Li R; Elmongy H; Sims C; Diamond SL
    J Trauma Acute Care Surg; 2016 Mar; 80(3):440-9. PubMed ID: 27082706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalable manufacture of a disposable, storage-stable eight-channel microfluidic device for rapid testing of platelet, coagulation, and drug function under whole blood flow.
    Rossi JM; Diamond SL
    Biomicrofluidics; 2020 Sep; 14(5):054103. PubMed ID: 33014235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.
    Thomassen S; Mastenbroek TG; Swieringa F; Winckers K; Feijge MAH; Schrijver R; Cosemans JMEM; Maroney SA; Mast AE; Hackeng TM; Heemskerk JWM
    Thromb Haemost; 2018 Mar; 118(3):502-513. PubMed ID: 29452445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
    Zhu S; Chen J; Diamond SL
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.